MB
SLDB icon

MPM BioImpact’s Solid Biosciences SLDB Stock Holding History

MPM BioImpact’s Portfolio SLDB Stock Details SLDB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-1,634,569
Closed -$10.1M – 49
2025
Q3 		$10.1M Hold
1,634,569
– – 1.65% 29
2025
Q2 		$7.96M Sell
1,634,569
-7,787
-0.5% -$27.5K 1.38% 33
2025
Q1 		$6.08M Buy
+1,642,356
New +$7.03M 1.04% 35
2024
Q4 		– Sell
-11,518
Closed -$80.3K – 53
2024
Q3 		$80.3K Buy
+11,518
New +$93.4K 0.01% 43

Other funds holding SLDB

PA
Perceptive Advisors New York $5.06B AUM 314.02% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return
AC
Armistice Capital New York $3.03B AUM 36.06% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $57.5B AUM 55.25% 1-Year Est. Return